Logo image of ALHUN.PA

HUNYVERS SACA (ALHUN.PA) Stock Fundamental Analysis

EPA:ALHUN - Euronext Paris - Matif - FR0014007LQ2 - Common Stock - Currency: EUR

8.84  -0.1 (-1.12%)

Fundamental Rating

4

Overall ALHUN gets a fundamental rating of 4 out of 10. We evaluated ALHUN against 49 industry peers in the Specialty Retail industry. ALHUN has a medium profitability rating, but doesn't score so well on its financial health evaluation. ALHUN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year ALHUN was profitable.
In the past year ALHUN has reported a negative cash flow from operations.
Each year in the past 5 years ALHUN has been profitable.
Of the past 5 years ALHUN 4 years had a positive operating cash flow.
ALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

ALHUN has a better Return On Assets (1.91%) than 61.22% of its industry peers.
With a decent Return On Equity value of 6.43%, ALHUN is doing good in the industry, outperforming 61.22% of the companies in the same industry.
ALHUN has a better Return On Invested Capital (5.48%) than 63.27% of its industry peers.
ALHUN had an Average Return On Invested Capital over the past 3 years of 9.61%. This is in line with the industry average of 8.30%.
The last Return On Invested Capital (5.48%) for ALHUN is well below the 3 year average (9.61%), which needs to be investigated, but indicates that ALHUN had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.91%
ROE 6.43%
ROIC 5.48%
ROA(3y)4.38%
ROA(5y)3.79%
ROE(3y)13.52%
ROE(5y)19.81%
ROIC(3y)9.61%
ROIC(5y)8.35%
ALHUN.PA Yearly ROA, ROE, ROICALHUN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

Looking at the Profit Margin, with a value of 1.41%, ALHUN is in the better half of the industry, outperforming 63.27% of the companies in the same industry.
In the last couple of years the Profit Margin of ALHUN has declined.
ALHUN's Operating Margin of 2.48% is in line compared to the rest of the industry. ALHUN outperforms 59.18% of its industry peers.
In the last couple of years the Operating Margin of ALHUN has declined.
ALHUN has a worse Gross Margin (19.89%) than 75.51% of its industry peers.
In the last couple of years the Gross Margin of ALHUN has grown nicely.
Industry RankSector Rank
OM 2.48%
PM (TTM) 1.41%
GM 19.89%
OM growth 3Y-16.85%
OM growth 5YN/A
PM growth 3Y-26.74%
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5YN/A
ALHUN.PA Yearly Profit, Operating, Gross MarginsALHUN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

3

2. Health

2.1 Basic Checks

ALHUN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ALHUN has about the same amount of shares outstanding.
Compared to 5 years ago, ALHUN has more shares outstanding
The debt/assets ratio for ALHUN is higher compared to a year ago.
ALHUN.PA Yearly Shares OutstandingALHUN.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALHUN.PA Yearly Total Debt VS Total AssetsALHUN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ALHUN has an Altman-Z score of 2.35. This is not the best score and indicates that ALHUN is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ALHUN (2.35) is comparable to the rest of the industry.
ALHUN has a Debt/Equity ratio of 0.71. This is a neutral value indicating ALHUN is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.71, ALHUN perfoms like the industry average, outperforming 46.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z 2.35
ROIC/WACC0.85
WACC6.46%
ALHUN.PA Yearly LT Debt VS Equity VS FCFALHUN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.66 indicates that ALHUN should not have too much problems paying its short term obligations.
ALHUN's Current ratio of 1.66 is fine compared to the rest of the industry. ALHUN outperforms 75.51% of its industry peers.
ALHUN has a Quick Ratio of 1.66. This is a bad value and indicates that ALHUN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.46, ALHUN perfoms like the industry average, outperforming 44.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 0.46
ALHUN.PA Yearly Current Assets VS Current LiabilitesALHUN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALHUN have decreased strongly by -52.70% in the last year.
The Earnings Per Share has been decreasing by -8.23% on average over the past years.
Looking at the last year, ALHUN shows a quite strong growth in Revenue. The Revenue has grown by 15.96% in the last year.
The Revenue has been growing by 26.45% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-52.7%
EPS 3Y-8.23%
EPS 5YN/A
EPS Q2Q%-1.2%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y26.45%
Revenue growth 5YN/A
Sales Q2Q%17.55%

3.2 Future

ALHUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.58% yearly.
Based on estimates for the next years, ALHUN will show a small growth in Revenue. The Revenue will grow by 4.70% on average per year.
EPS Next Y8.84%
EPS Next 2Y20.66%
EPS Next 3Y18.72%
EPS Next 5Y25.58%
Revenue Next Year12.96%
Revenue Next 2Y8.73%
Revenue Next 3Y7.16%
Revenue Next 5Y4.7%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALHUN.PA Yearly Revenue VS EstimatesALHUN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
ALHUN.PA Yearly EPS VS EstimatesALHUN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.42, which indicates a rather expensive current valuation of ALHUN.
Based on the Price/Earnings ratio, ALHUN is valued a bit cheaper than 77.55% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALHUN to the average of the S&P500 Index (26.98), we can say ALHUN is valued slightly cheaper.
ALHUN is valuated reasonably with a Price/Forward Earnings ratio of 10.73.
ALHUN's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALHUN is cheaper than 81.63% of the companies in the same industry.
ALHUN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.49.
Industry RankSector Rank
PE 18.42
Fwd PE 10.73
ALHUN.PA Price Earnings VS Forward Price EarningsALHUN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALHUN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.82
ALHUN.PA Per share dataALHUN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ALHUN's earnings are expected to grow with 18.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.08
PEG (5Y)N/A
EPS Next 2Y20.66%
EPS Next 3Y18.72%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALHUN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HUNYVERS SACA

EPA:ALHUN (6/27/2025, 7:00:00 PM)

8.84

-0.1 (-1.12%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.77%
Inst Owner ChangeN/A
Ins Owners2.63%
Ins Owner ChangeN/A
Market Cap34.21M
Analysts88
Price Target11.88 (34.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.67%
PT rev (3m)-17.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE 18.42
Fwd PE 10.73
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 1.2
P/tB 2.15
EV/EBITDA 12.82
EPS(TTM)0.48
EY5.43%
EPS(NY)0.82
Fwd EY9.32%
FCF(TTM)-1.34
FCFYN/A
OCF(TTM)-1.13
OCFYN/A
SpS33.68
BVpS7.38
TBVpS4.12
PEG (NY)2.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.91%
ROE 6.43%
ROCE 6.65%
ROIC 5.48%
ROICexc 6.59%
ROICexgc 9.48%
OM 2.48%
PM (TTM) 1.41%
GM 19.89%
FCFM N/A
ROA(3y)4.38%
ROA(5y)3.79%
ROE(3y)13.52%
ROE(5y)19.81%
ROIC(3y)9.61%
ROIC(5y)8.35%
ROICexc(3y)11.28%
ROICexc(5y)11.76%
ROICexgc(3y)15.77%
ROICexgc(5y)16.95%
ROCE(3y)12.12%
ROCE(5y)10.83%
ROICexcg growth 3Y-40.67%
ROICexcg growth 5YN/A
ROICexc growth 3Y-38.4%
ROICexc growth 5YN/A
OM growth 3Y-16.85%
OM growth 5YN/A
PM growth 3Y-26.74%
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5YN/A
F-Score4
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 5.16
Cap/Depr 114.18%
Cap/Sales 0.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 0.46
Altman-Z 2.35
F-Score4
WACC6.46%
ROIC/WACC0.85
Cap/Depr(3y)138.87%
Cap/Depr(5y)108.48%
Cap/Sales(3y)0.8%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.7%
EPS 3Y-8.23%
EPS 5YN/A
EPS Q2Q%-1.2%
EPS Next Y8.84%
EPS Next 2Y20.66%
EPS Next 3Y18.72%
EPS Next 5Y25.58%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y26.45%
Revenue growth 5YN/A
Sales Q2Q%17.55%
Revenue Next Year12.96%
Revenue Next 2Y8.73%
Revenue Next 3Y7.16%
Revenue Next 5Y4.7%
EBIT growth 1Y-40.5%
EBIT growth 3Y5.15%
EBIT growth 5YN/A
EBIT Next Year42.55%
EBIT Next 3Y22.31%
EBIT Next 5Y24.53%
FCF growth 1Y-2895.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-494.17%
OCF growth 3YN/A
OCF growth 5YN/A